Molecular Templates Inc. (MTEM)
$0.00
$0.00
(-96.15%)
As on 20-May-2025 09:30EDT
Market cap
$0 Mln
Revenue (TTM)
$25 Mln
P/E Ratio
--
P/B Ratio
0
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-9.3 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
0.1
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-1.1
-
Face value
--
-
Shares outstanding
6,583,880
10 Years Aggregate
CFO
$-379.84 Mln
EBITDA
$-169.77 Mln
Net Profit
$-200.06 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Molecular Templates (MTEM)
| -99.8 | -- | -- | -100.0 | -98.2 | -94.7 | -79.2 |
|
BSE Sensex*
| -12.6 | -4.3 | -4.6 | -10.3 | 5.7 | 7.3 | 10.7 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|---|---|---|---|---|---|---|---|
|
Molecular Templates (MTEM)
| -98.6 | -24.2 | -91.6 | -58.3 | -32.9 | 246.2 | -59.5 |
|
S&P Small-Cap 600
| 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 | -9.7 |
|
BSE Sensex
| 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 | 5.9 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Molecular Templates (MTEM)
|
0.0 | 0.0 | 25.5 | -7.3 | -63.5 | -129.3 | -- | 0.0 |
| 5.0 | 266.1 | 48.4 | -4.1 | -122.7 | -1.9 | -- | 1.2 | |
| 2.0 | 3.7 | 0.1 | -12.4 | -10,272.1 | -352.5 | -- | 9.9 |
Shareholding Pattern
View DetailsAbout Molecular Templates (MTEM)
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases in the United States. The company develops therapies... through its proprietary biologic drug platform technology (ETB). It is also developing MT- 8421, an ETB candidate that is in Phase I clinical trial for the treatment of dismantling TME through direct cell-kill of tumor and immune cell; MT-0169, which is in Phase I clinical trial to treat relapsed/refractory multiple myeloma; and MT-6402 in that is in Phase I clinical trial for relapsed/refractory patients with PD-L1 expressing tumors. The company has a collaboration agreement with Bristol Myers Squibb to discover and develop novel products containing ETBs directed to multiple targets. Molecular Templates, Inc. was founded in 2001 and is headquartered in Austin, Texas. On April 20, 2025, Molecular Templates, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. Read more
-
CEO, Chief Scientific Officer & Director
Dr. Eric E. Poma Ph.D.
-
CEO, Chief Scientific Officer & Director
Dr. Eric E. Poma Ph.D.
-
Headquarters
Austin, TX
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Molecular Templates (MTEM)
What is the current share price of Molecular Templates Inc (MTEM) Today?
The share price of Molecular Templates Inc (MTEM) is $0.00 (NASDAQ) as of 20-May-2025 09:30 EDT. Molecular Templates Inc (MTEM) has given a return of -98.19% in the last 3 years.
What is the current PB & PE ratio of Molecular Templates Inc (MTEM)?
Since, TTM earnings of Molecular Templates Inc (MTEM) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2023
|
-2.47
|
4.76
|
|
2022
|
-0.01
|
-0.08
|
|
2021
|
-0.19
|
0.22
|
|
2020
|
0.30
|
0.53
|
|
2019
|
-0.54
|
0.37
|
What is the 52 Week High and Low of Molecular Templates Inc (MTEM)?
The 52-week high and low of Molecular Templates Inc (MTEM) are Rs -- and Rs -- as of 10-Jun-2026.
What is the market cap of Molecular Templates Inc (MTEM)?
Molecular Templates Inc (MTEM) has a market capitalisation of $ 0 Mln as on 20-May-2025. As per SEBI classification, it is a Small Cap company.
Should I invest in Molecular Templates Inc (MTEM)?
Before investing in Molecular Templates Inc (MTEM), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.